University of Alberta chemists have developed new tools for studying the human immune system that lay the foundation for research that could improve understanding of cancer and neurodegenerative diseases such as Alzheimer's.
Cell & Microbiology
Oct 12, 2020
0
57
The Centers for Disease Control and Prevention (CDC) has prioritized finding effective treatment of Methicillin-resistant Staphylococcus aureus (MRSA), one of the most common bacterial pathogens and the single most deadly ...
Biotechnology
Sep 3, 2020
0
93
The pathogenic fungus Candida auris, which first surfaced in 2009, is proving challenging to control. It is resistant to many fungicides and not easy to diagnose. Researchers from Radboud university medical center, Canisius-Wilhelmina ...
Cell & Microbiology
Aug 28, 2020
0
61
A team of developmental biologists at the Morgridge Institute for Research has discovered a means by which schistosomes, parasitic worms that infect more than 200 million people in tropical climates, are able to outfox the ...
Molecular & Computational biology
Jul 27, 2020
0
172
A key set of proteins that help regulate hormones necessary for many essential functions in humans and other vertebrates have ancient origins in much simpler creatures such as sea cucumbers, says a new study published today ...
Molecular & Computational biology
Jun 9, 2020
0
283
Devastated by summer's unprecedented firestorms, Australia's koalas are facing a potentially more serious and enduring existential threat from a fellow mammal—the bat.
Plants & Animals
Apr 14, 2020
0
249
A team of physicists from McMaster University has developed a process to modify red blood cells so they can be used to distribute drugs throughout the body, which could specifically target infections or treat catastrophic ...
Cell & Microbiology
Jan 16, 2020
0
136
A lab goof with an enzyme taken from bacteria has led to the creation of the Leviathan of polymer brushes, emerging biocompatible materials with the potential to repel infectious bacteria.
Polymers
Jan 13, 2020
0
49
A computational model could improve the selection of tumor antigens for personalized cancer vaccines that are now in early-stage clinical trials.
Biotechnology
Dec 17, 2019
0
20
In a paper published in Cell Reports, a team of researchers from the Department of Energy's SLAC National Accelerator Laboratory and Stanford University discovered unique characteristics of a protein called VISTA that protects ...
Biochemistry
Nov 18, 2019
0
154
